Routine Osteoporosis Screening Recommended

DECEMBER 01, 2002
The US Preventive Services Task Force has recommended that women aged 65 and older be routinely screened for osteoporosis to reduce the risk of fracture and spinal abnormalities often associated with the disease. The task force also recommended that routine screening begin at age 60 for those women identified as at high risk because of their weight or estrogen use. The recommendations, which are published in the Annals of Internal Medicine, mark the first time the task force has called for routine osteoporosis screening. The task force found that dual-energy x-ray absorptiometry is the most accurate method for measuring bone density.

SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.